Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD
Conditions: Coronary Artery Disease; Diabetes Mellitus, Type 2 Interventions: Drug: Vildagliptin 50 mg Oral Tablet; Drug: Metformin 1000 mg Oral Tablet; Drug: Glimepiride 4 mg Oral Tablet Sponsor: Damanhour University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials